Koyi ko ko Arthri-D3 ya yi amfani da cututtukan Arthritis

Faɗakar da Gaskiya Daga Hannun Hoto

Arthri-D3 wani karin abincin abincin da aka inganta a kan talabijin na talabijin a matsayin hanyar kawar da ciwo na arthritis. Dukansu kamfanoni da kuma shafin yanar gizon Arthri-D3 sun bayyana cewa "wata hanyar juyin juya hali ce wadda ta haɗu da ɗaya daga cikin maki mafi girma na glucosamine tare da tsire-tsire masu tsire-tsire."

Hanyoyin Sinada

Abu mai mahimmanci a cikin Arthri-D3 shine N-acetyl-glucosamine (NAG) , nau'in glucosamine wanda aka samar ta jiki cikin jiki.

Don abincin abincin da ake ci kamar Arthri-D3, siffar da aka yi amfani da shi yana fitowa daga gashin murkoki. Bugu da ƙari, ga NAG, jerin abubuwan da ke aiki sun haɗa da:

Bayani don Amfani

Babu wasu alamomi na musamman game da Arthri-D3 ba tare da inganta kiwon lafiyar jama'a ba. Kalmar nan "Arthi" tana nufin cewa yana da amfani na arthritis, ko da yake babu maganganun wariyar launin fata ko wani nau'in haɗin gwiwa (irin su bursitis ko tendinitis ) a cikin kamfanin kasuwanci.

Arthi-D3 ba za a iya amfani dasu ba a cikin mutane masu fama da allergy .

Bayanan magani

Kowane kwalban Arthri-D3 ya ƙunshi nauyin wata guda na 120 capsules.

Mai sana'anta ya bada shawarar daukar matuka biyu a safiya da biyu capsules da rana ko maraice, zai fi dacewa tare da abinci. Saboda Vitamin D shine mai narkewa mai sauƙi, zai fi dacewa da abinci.

Har ila yau, masana'antun sun ba da shawarar cewa ku ɗauki ƙarin don akalla watanni uku don "jin nauyin amfaninsa," kodayake ba a bayyana a fili abin da waɗannan alamun zasu iya zama ba.

Kudin Samfur

Kudin da aka samu na Arthri-D3 na wata guda shine $ 104.99 tare da cajin da ake biyan kuɗi na $ 10.49.

Ta hanyar kwatanta, farashin lambobin 120 na IU bitamin D3 shine kimanin $ 8.00. Hakazalika, ƙididdigar 120 na NAG na 700-milligram shine kimanin $ 13.00.

Clinical Research

Tashar yanar gizo Arthri-D3 ba ta lissafa duk wani shaida a cikin goyon baya ga ƙididdiga ba banda su haɗa da wasu ƙwaƙwalwa daga abokan ciniki (sunaye na farko).

A matsayin karin abincin abincin, Cibiyar Abinci da Drug ta Amurka ba ta buƙatar cewa Athri-D3 ba ta buƙatar irin wannan gwajin gwaji da aka gano da kwayoyin magani. Duk da yake ba a yarda da masu yin amfani da abincin abincin abinci ba don yin ƙarya game da samfurorin su, masana'antu a matsayin cikakkun an tsara su da kyau kuma mafi yawa sun bar 'yan sanda kanta.

Wannan ba ya nuna cewa glucosamine ba cikakke ba ne a cikin amfaninta ga mutanen dake da ciwon maganin ƙwaro. Matsalar ita ce mafi yawan karatun, irin su wannan da aka yi a Jami'ar Juntendo a Tokyo a 2016 da 2017, suna da ƙananan kuma gajere don rage iyakar da zasu iya kusantar da su.

Sauran binciken, irin su nazarin nazarin Nazarin Jami'ar Liège a shekarar 2012, haɗin gwiwa da masana'antun da aka haɓaka.

Ƙarshe

Duk da yake mafi yawan masu bincike za su yarda da cewa glucosamine na iya ba da dama ga mutanen da ke fama da ciwo na arthritis, za su kuma tabbatar da cewa babu wata hanya ta san abin da, idan wani ya shafi tasirin zai ci gaba da ci gaba da ci gaba da kuma dalilin da yasa ake samun amfanoni a wasu nazarin ba a wasu ba.

Wannan duniyar ta raba ta da Cibiyar Nazarin Ƙwararren Orthopedic American Academy, wadda ta ce: "Babu tabbacin cewa [glucosamine] za ta rage jinkirin aikin ciwo ko mayar da kayan tiyata a hadadun arthritic."

> Sources:

> Cibiyar Nazarin Kwararrun Orthopedic Amirka (AAOS). (2009) "Glucosamine da Chondroitin Sulfate." Binciken AAOS Research Committee, Osteoarthritis, da kuma Arthritis Foundation. Rosemont, Illinois: AAOS.

> Henrotin, Y .; Mobasheri, A ;; da kuma Marty, M. "Shin akwai wata hujja ta kimiyya don amfani da glucosamine a cikin kula da aikin osteoarthritis?" Arthritis Res Ther. 2012; 14 (1): 201. DOI: 10.1186 / ar3657.

> Kubomura, D .; Ueno, T. Yamada, M. et al. "Hanyoyin N-acetylglucosamine a kan gwanintattun metabolism da aminci a cikin batutuwa masu lafiya ba tare da bayyanar cututtuka ba. Exp Ther Med. 2017; 13 (4): 1614-21. DOI: 10.3892 / etm.2017.4140.

> Tomonaga, A ;; Watanabe, K .; Fukagawa, M. et al. "Bincike akan tasirin N-acetyl-glucosamine a kan masu kare rayuka a jikin gwargwadon furotin a cikin mutane masu lafiya ba tare da alamar cututtuka ba. Exp Ther Med. 2016; 12 (3): 1481-89. DOI: 10.3892 / etm.2016.3480.